Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Technology

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
21.05.ATS 2025: Real-world cohort study aligns with GSK depemokimab narrative
21.05.WHO secures 20% funding increase amid US shortfall
21.05.ATS 2025: GSK strengthens argument for twice-annual depemokimab
21.05.BioNTech to invest up to $1.34bn in UK R&D
21.05.FDA to restrict Covid-19 booster doses to older adults
20.05.HHS sets "most favoured nation" pricing targets for drug makers
20.05.China's mAb and ADC licensing was 3xUS's in 2024 - will trade tensions slow it?
20.05.ATS 2025: Sanofi and Regeneron to launch new AIM4 trial for personalised asthma care
20.05.ATS 2025: ETI-linked mucus clearance tied to lung function gains in paediatric CF
20.05.Skye and Arecor to develop higher formulation of CB1 inhibitor
20.05.London Biotechnology Show Makes Grand Return to Unveil Cutting-edge Advances in Health & Medicine
20.05.Next-Gen Pharma: AI, ML & Digital Twins Converge at AUTOMA+ 2025
20.05.Pharmaceutical Technology Excellence Awards 2025: Novotech
20.05.Countries formally adopt WHO's Pandemic Agreement for future pandemics
20.05.Japan's MHLW approves GSK's Blenrep combos for multiple myeloma
20.05.ATS 2025: Anti-IL-5 therapy cuts exacerbations in coexisting COPD and asthma patients
20.05.ATS 2025: Real-world data supports Trikafta as gold standard in long-term CF care
20.05.Pfizer signs global licensing deal with 3SBio for bispecific antibody
19.05.Power of collaboration more pertinent than ever says pharma experts
19.05.Regeneron buys bankrupt 23andMe for $256m
19.05.Apnimed to seek approval for sleep apnoea pill after Phase III success
19.05.Five years, one approval: Europe's slow march on Alzheimer's treatments
19.05.FDA approves Incyte's retifanlimab combo for SCAC treatment
19.05.Novo Nordisk's CEO to step down as weight loss market share plummets
19.05.EC approves BMS' perioperative Opdivo and chemo for NSCLC